Vicki Thallas-Bonke Selected Research

Vicki Thallas-Bonke Research Topics

Disease

19	Diabetic Nephropathies (Diabetic Nephropathy) 04/2021 - 01/2004
10	Albuminuria 04/2021 - 11/2004
5	Fibrosis (Cirrhosis) 04/2021 - 01/2013
4	Inflammation (Inflammations) 01/2021 - 05/2015
2	Chronic Disease (Chronic Diseases) 10/2011 - 07/2011
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2011 - 08/2005
1	Hyperglycemia 10/2017
1	Chronic Renal Insufficiency 01/2016
1	Diabetes Complications 05/2015
1	Diabetes Mellitus 05/2015
1	Body Weight (Weight, Body) 01/2014
1	Obesity 07/2011
1	Weight Gain 07/2011
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2010
1	Atherosclerosis 04/2007

Drug/Important Bio-Agent (IBA)

10	Advanced Glycation End ProductsIBA 01/2019 - 01/2004
4	Proteins (Proteins, Gene)FDA Link 10/2017 - 09/2006
4	NADPH Oxidases (NAD(P)H oxidase)IBA 10/2017 - 02/2008
4	alagebriumIBA 10/2011 - 11/2004
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 02/2008
3	Protein Isoforms (Isoforms)IBA 01/2021 - 11/2004
3	Streptozocin (Streptozotocin)FDA Link 10/2017 - 06/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2016 - 11/2004
3	Receptor for Advanced Glycation End ProductsIBA 01/2014 - 08/2005
3	Superoxides (Superoxide)IBA 10/2011 - 04/2009
2	Complement C5a (Complement 5a)IBA 01/2021 - 01/2020
2	CollagenIBA 10/2017 - 01/2013
2	Fibronectins (Fibronectin)IBA 10/2017 - 11/2004
2	Apolipoproteins E (ApoE)IBA 06/2014 - 04/2007
2	Extracellular Matrix ProteinsIBA 06/2014 - 11/2004
2	AngiotensinsIBA 01/2010 - 08/2005
2	Protein Kinase C-alphaIBA 02/2008 - 11/2004
1	MitoGamideIBA 04/2021
1	Pyruvaldehyde (Methylglyoxal)IBA 04/2021
1	Oxidoreductases (Dehydrogenase)IBA 01/2021
1	NADP (NADPH)IBA 01/2021
1	alisporivirIBA 01/2020
1	Cyclophilins (Cyclophilin)IBA 01/2020
1	Mitochondrial Permeability Transition PoreIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Complement System Proteins (Complement)IBA 01/2020
1	ChemokinesIBA 10/2017
1	TRPC6 Cation ChannelIBA 10/2017
1	nephrinIBA 02/2016
1	Apoptosis Inducing FactorIBA 01/2016
1	compound 21IBA 05/2015
1	Type 1 Angiotensin ReceptorIBA 05/2015
1	Type 2 Angiotensin ReceptorIBA 05/2015
1	Angiotensin IIIBA 05/2015
1	Cystatin CIBA 05/2015
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 06/2014
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2014
1	Ramipril (Altace)FDA LinkGeneric 01/2014
1	AlbuminsIBA 07/2011
1	CreatinineIBA 07/2011
1	Dietary Advanced Glycation End ProductsIBA 03/2010
1	ChloridesIBA 03/2010
1	Adenosine Triphosphate (ATP)IBA 03/2010
1	Antihypertensive Agents (Antihypertensives)IBA 01/2010
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2010
1	acetovanillone (apocynin)IBA 02/2008
1	EnzymesIBA 04/2007
1	Glutathione (Reduced Glutathione)IBA 04/2007
1	AntioxidantsIBA 04/2007
1	ApolipoproteinsIBA 04/2007
1	Perindopril FDA LinkGeneric 08/2005
1	Laminin (Merosin)IBA 11/2004
1	Protein Kinase CIBA 11/2004
1	SugarsIBA 01/2004

Therapy/Procedure

2	Therapeutics 01/2010 - 02/2007
1	Glycemic Control 07/2011